Ko D, Chung MK, Evans PT, Benjamin EJ, Helm RH. Atrial Fibrillation: A Review. JAMA. 2025;333:329–42. https://doi.org/10.1001/jama.2024.22451.
Article CAS PubMed PubMed Central Google Scholar
Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118:2498–505. https://doi.org/10.1161/CIRCULATIONAHA.108.772582.
Latchamsetty R, Morady F. Atrial Fibrillation Ablation. Annu Rev Med. 2018;69:53–63. https://doi.org/10.1146/annurev-med-041316-090015.
Article CAS PubMed Google Scholar
Marrouche NF, Brachmann J, Andresen D, CASTLE-AF Investigators, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27. https://doi.org/10.1056/NEJMoa1707855.
Zakeri R, Chamberlain AM, Roger VL, Redfield MM. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation. 2013;128:1085–93. https://doi.org/10.1161/CIRCULATIONAHA.113.001475.
Article PubMed PubMed Central Google Scholar
Kotecha D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, Voors AA, Rienstra M. Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins. J Am Coll Cardiol. 2016;68:2217–28. https://doi.org/10.1016/j.jacc.2016.08.048.
Hamo CE, DeJong C, Hartshorne-Evans N, et al. Heart failure with preserved ejection fraction. Nat Rev Dis Primers. 2024;10(1):55. https://doi.org/10.1038/s41572-024-00540-y.
Sohns C, Marrouche NF. Atrial fibrillation and cardiac fibrosis. Eur Heart J. 2020;41:1123–31. https://doi.org/10.1093/eurheartj/ehz786.
Article CAS PubMed Google Scholar
Chieng D, Sugumar H, Segan L, et al. Atrial fibrillation ablation for heart failure with preserved ejection fraction: A randomized controlled trial. JACC Heart Fail. 2023;11:646–58. https://doi.org/10.1016/j.jchf.2023.01.008.
Article CAS PubMed Google Scholar
Fujimoto H, Doi N, Okayama S, et al. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction. Europace. 2022;24:576–86. https://doi.org/10.1093/europace/euab201.
Siddiqui MU, Junarta J, Riley JM, et al. Catheter ablation in patients with atrial fibrillation and heart failure with preserved ejection fraction: a systematic review and meta-analysis. J Arrhythm. 2022;38:981–90. https://doi.org/10.1002/joa3.12794.
Article PubMed PubMed Central Google Scholar
Lau DH, Linz D, Schotten U, Mahajan R, Sanders P, Kalman JM. Pathophysiology of paroxysmal and persistent atrial fibrillation: rotors, foci and fibrosis. Heart Lung Circ. 2017;26:887–93. https://doi.org/10.1016/j.hlc.2017.05.119.
Khan HR, Yakupoglu HY, Kralj-Hans I, et al. Left atrial function predicts atrial arrhythmia recurrence following ablation of long-standing persistent atrial fibrillation. Circ Cardiovasc Imaging. 2023;16:e015352. https://doi.org/10.1161/CIRCIMAGING.123.015352.
Article PubMed PubMed Central Google Scholar
Chinese Expert Consensus Working Group on Diagnosis and Treatment of Heart Failure With Preserved Ejection Fraction. Diagnosis and treatment of heart failure with preserved ejection fraction: Chinese expert consensus 2023. Chin Circulation J. 2023. https://doi.org/10.3969/j.issn.1000-3614.2023.04.001.
Menichelli D, Antonucci E, Gazzaniga G, et al. Atrial fibrillation, heart failure phenotypes, and mortality risk in the nationwide START registry: a propensity score matching analysis. J Am Heart Assoc. 2025;14:e042586. https://doi.org/10.1161/JAHA.125.042586.
Article PubMed PubMed Central Google Scholar
Younis A, Tabaja C, Santangeli P, et al. Outcomes of atrial fibrillation ablation in heart failure subtypes. Circulation: Arrhythmia and Electrophysiology. 2024;17:e012926. https://doi.org/10.1161/CIRCEP.124.012926.
Article CAS PubMed Google Scholar
Hashem C, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Yuyun MF. Atrial fibrillation recurrence post-ablation across heart failure categories: a systematic review and meta-analysis. Cardiol Res. 2025;16:33–43. https://doi.org/10.14740/cr2020.
Article PubMed PubMed Central Google Scholar
Chen C, Cheng K, Gao X, et al. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction. ESC Heart Fail. 2023;10(1):518–31. https://doi.org/10.1002/ehf2.14212.
Mekhael M, Shan B, Noujaim C, et al. Catheter ablation improved ejection fraction in persistent AF patients: a DECAAF-II sub analysis. Europace. 2023;25:889–95. https://doi.org/10.1093/europace/euad018.
Article PubMed PubMed Central Google Scholar
McManus DD, Yin X, Gladstone R, et al. Alcohol consumption, left atrial diameter, and atrial fibrillation. J Am Heart Assoc. 2016;5:e004060. https://doi.org/10.1161/JAHA.116.004060.
Article PubMed PubMed Central Google Scholar
Fu F, Pietropaolo M, Cui L, et al. Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models. PLoS One. 2022;17:e0256512. https://doi.org/10.1371/journal.pone.0256512.
Article CAS PubMed PubMed Central Google Scholar
Mueller C, McDonald K, de Boer RA, et al. Heart failure association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21:715–31. https://doi.org/10.1002/ejhf.1494.
Article CAS PubMed Google Scholar
Ding WY, Protty MB, Davies IG, Lip GYH. Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc Res. 2022;118:716–31. https://doi.org/10.1093/cvr/cvab017.
Article CAS PubMed Google Scholar
Okawa K, Sogo M, Morimoto T, et al. Relationship between endothelial dysfunction and the outcomes after atrial fibrillation ablation. J Am Heart Assoc. 2023;12:e028482. https://doi.org/10.1161/JAHA.122.028482.
Article PubMed PubMed Central Google Scholar
Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:1500–15. https://doi.org/10.1161/CIRCRESAHA.114.303772.
Article CAS PubMed PubMed Central Google Scholar
Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120. https://doi.org/10.1186/s12933-017-0604-9.
Article CAS PubMed PubMed Central Google Scholar
Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124:2264–74. https://doi.org/10.1161/CIRCULATIONAHA.111.019893.
Article CAS PubMed Google Scholar
Tai BY, Wen ZH, Cheng PY, et al. Lemnalol modulates the electrophysiological characteristics and calcium homeostasis of atrial myocytes. Mar Drugs. 2019;17:619. https://doi.org/10.3390/md17110619.
Article CAS PubMed PubMed Central Google Scholar
Matteucci A, Russo M, Galeazzi M, et al. Impact of ablation energy sources on perceived quality of life and symptom in atrial fibrillation patients: a comparative study. J Clin Med. 2025;14(8):2741. https://doi.org/10.3390/jcm14082741.
Comments (0)